Skip Main Navigation

Doug Farrell

Vice President of Investor Relations  |  NanoString Technologies

Doug Farrell has joined NanoString Technologies (NSTG) as Vice President of Investor Relations and Corporate Communications. Mr. Farrell brings 30 years of experience in the Life Sciences industry. Before joining NanoString, Doug was Vice President of Investor Relations and Treasury for 13 years at Affymetrix, a leading provider of tools for genetic research. Doug’s previous experience includes serving as Senior Director of Investor Relations at Aurora Biosciences, which was acquired by Vertex Pharmaceutics, as well as The Liposome Company, which was acquired by Elan Corporation. Prior to joining The Liposome Company, Doug was a Division Manager and Clinical Marketing Specialist at Genentech for 4 years. Doug began his career at Schering Pharmaceuticals where he worked in Sales and Marketing for 3 years. Doug received a B.S. in Business Administration from Northeastern University, with a dual major in International Business and Marketing. He is a graduate of the Corporate Governance Institute at San Diego State University and has been a member of the National Investor Relations Institute since 1998.